English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Delta Np63 alpha promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82

MPS-Authors
/persons/resource/persons208862

Pecoraro,  M.
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

onc201742a.pdf
(Publisher version), 5MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Di Giacomo, V., Tian, T. V., Mas, A., Pecoraro, M., Batlle-Morera, L., Noya, L., et al. (2017). Delta Np63 alpha promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82. Oncogene, 36(31), 4381-4392. doi:10.1038/onc.2017.42.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-D72D-0
Abstract
Delta Np63 alpha is a critical mediator of epithelial development and stem cell function in a variety of tissues including the skin and breast, while overexpression of Delta Np63 alpha acts as an oncogene to drive tumor formation and cancer stem cell properties in squamous cell carcinoma. However, with regards to the prostate, while Delta Np63 alpha is expressed in the basal stem cells of the mature gland, during adenocarcinoma development, its expression is lost and its absence is used to clinically diagnose the malignant state. Surprisingly, here we identify a sub-population of bone metastatic prostate cancer cells in the PC3 cell line that express Delta Np63 alpha. Interestingly, we discovered that Delta Np63 alpha favors adhesion and stem-like growth of these cells in the bone microenvironment. In addition, we show that these properties require expression of the target gene CD82. Together, this work uncovers a population of bone metastatic prostate cancer cells that express Delta Np63 alpha, and provides important information about the mechanisms of bone metastatic colonization. Finally, we identify metastasis-promoting properties for the tetraspanin family member CD82.